{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:17:55Z","timestamp":1778879875905,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cld.2026.01.008","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:44:07Z","timestamp":1772228647000},"page":"469-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["What\u2019s New in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis"],"prefix":"10.1016","volume":"30","author":[{"given":"Lorenzo","family":"D\u2019Antiga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emer","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey B.","family":"Schwimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cld.2026.01.008_bib1","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jpn3.12156","article-title":"Paediatric steatotic liver disease has unique characteristics: a multisociety statement endorsing the new nomenclature","volume":"78","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.cld.2026.01.008_bib2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S2468-1253(23)00100-0","volume":"8","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2026.01.008_bib3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/apt.14900","article-title":"Hepatic steatosis is highly prevalent across the paediatric age spectrum, including in pre-school age children","volume":"48","author":"Dhaliwal","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cld.2026.01.008_bib4","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1542\/peds.2006-1212","article-title":"Prevalence of fatty liver in children and adolescents","volume":"118","author":"Schwimmer","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.cld.2026.01.008_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpeds.2018.11.021","article-title":"Prevalence of nonalcoholic fatty liver disease in children with obesity","volume":"207","author":"Yu","year":"2019","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.cld.2026.01.008_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MPG.0000000000003795","article-title":"Prevalence of elevated ALT in adolescents in the US 2011-2018","volume":"77","author":"Mischel","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.cld.2026.01.008_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/HEP.0000000000001357","article-title":"Long-term mortality and extrahepatic outcomes in 1096 children with MASLD: a retrospective cohort study","volume":"83","author":"Schwimmer","year":"2026","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2026.01.008_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.cld.2026.01.008_bib9","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/apt.70022","article-title":"Prevalence and predictors of suspected metabolic dysfunction-associated steatotic liver disease in adolescents in the United States","volume":"61","author":"Noon","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cld.2026.01.008_bib10","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-0771","article-title":"Incidence of nonalcoholic fatty liver disease in children: 2009-2018","volume":"146","author":"Sahota","year":"2020","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.cld.2026.01.008_bib11","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1542\/peds.2004-1832","article-title":"Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents","volume":"115","author":"Schwimmer","year":"2005","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.cld.2026.01.008_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.13110","article-title":"Alanine aminotransferase elevation varies by ethnicity among Asian and Pacific Islander children with overweight or obesity","volume":"19","author":"Lee","year":"2024","journal-title":"Pediatr Obes"},{"issue":"4","key":"10.1016\/j.cld.2026.01.008_bib13","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/HEP.0000000000000383","article-title":"Global and national prevalence of nonalcoholic fatty liver disease in adolescents: an analysis of the global burden of disease study 2019","volume":"78","author":"Hartmann","year":"2023","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2026.01.008_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MPG.0000000000000618","article-title":"On the origin of pediatric nonalcoholic fatty liver disease","volume":"60","author":"Ugalde-Nicalo","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"10.1016\/j.cld.2026.01.008_bib15","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1210\/en.2016-1314","article-title":"Maternal obesity in pregnancy developmentally programs adipose tissue inflammation in young, lean Male mice offspring","volume":"157","author":"Alfaradhi","year":"2016","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.cld.2026.01.008_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrgastro.2016.160","article-title":"Developmental origins of NAFLD: a womb with a clue","volume":"14","author":"Wesolowski","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2026.01.008_bib17","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/hep.32540","article-title":"Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community-based cohort","volume":"76","author":"Amadou","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.01.008_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpeds.2017.03.007","article-title":"Low and high birth weights are risk factors for nonalcoholic fatty liver disease in children","volume":"187","author":"Newton","year":"2017","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.cld.2026.01.008_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298800","article-title":"Determinants of non-alcoholic fatty liver disease in young people: maternal, neonatal, and adolescent factors","volume":"19","author":"Nairz","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2026.01.008_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jpeds.2020.01.031","article-title":"Genetic risk for hepatic fat among an ethnically diverse cohort of youth: the exploring perinatal outcomes among children study","volume":"220","author":"Stanislawski","year":"2020","journal-title":"J Pediatr"},{"key":"10.1016\/j.cld.2026.01.008_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fimmu.2011.00049","article-title":"New insights into the role of macrophages in adipose tissue inflammation and fatty liver disease: modulation by endogenous omega-3 fatty Acid-derived lipid mediators","volume":"2","author":"Claria","year":"2011","journal-title":"Front Immunol"},{"issue":"18","key":"10.1016\/j.cld.2026.01.008_bib22","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1161\/CIRCULATIONAHA.107.704569","article-title":"Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females","volume":"117","author":"Moran","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cld.2026.01.008_bib23","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/HEP.0000000000001368","article-title":"AASLD practice statement on the evaluation and management of metabolic dysfunction-associated steatotic liver disease in children","volume":"82","author":"Xanthakos","year":"2025","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2026.01.008_bib24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jhep.2018.02.006","article-title":"Paediatric fatty liver disease (PeFLD): all is not NAFLD - pathophysiological insights and approach to management","volume":"68","author":"Hegarty","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2026.01.008_bib25","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cgh.2013.09.050","article-title":"Evidence and recommendations for imaging liver fat in children, based on systematic review","volume":"12","author":"Awai","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2026.01.008_bib26","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/hep.27666","article-title":"Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease","volume":"61","author":"Schwimmer","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2026.01.008_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MPG.0000000000002535","article-title":"Evaluation of quantitative imaging biomarkers for early-phase clinical trials of steatohepatitis in adolescents","volume":"70","author":"Goyal","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.cld.2026.01.008_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/gutjnl-2023-331090","article-title":"Metabolic dysfunction-associated steatotic liver disease in children","volume":"74","author":"Goyal","year":"2025","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2026.01.008_bib29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2017.02.030","article-title":"In children with nonalcoholic fatty liver disease, Zone 1 steatosis is associated with advanced fibrosis","volume":"16","author":"Africa","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2026.01.008_bib30","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/hep.29241","article-title":"Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease","volume":"66","author":"Schwimmer","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2026.01.008_bib31","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/jmri.26905","article-title":"Normal range for MR elastography measured liver stiffness in children without liver disease","volume":"51","author":"Sawh","year":"2020","journal-title":"J Magn Reson Imag"},{"issue":"6","key":"10.1016\/j.cld.2026.01.008_bib32","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/HEP.0000000000000644","article-title":"Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease","volume":"79","author":"Wang","year":"2024","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2026.01.008_bib33","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/HEP.0000000000001016","article-title":"Development and validation of pFIB scores for exclusion of significant liver fibrosis in pediatric MASLD","volume":"81","author":"Lefere","year":"2025","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2026.01.008_bib34","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/MPG.0b013e318252a13f","article-title":"Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN hepatology committee","volume":"54","author":"Vajro","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.cld.2026.01.008_bib35","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.jhep.2021.06.034","article-title":"Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality","volume":"75","author":"Simon","year":"2021","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2026.01.008_bib36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/gutjnl-2022-328105","article-title":"Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease","volume":"72","author":"Simon","year":"2023","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cld.2026.01.008_bib37","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cgh.2022.05.028","article-title":"Incidence of type 2 diabetes in children with nonalcoholic Fatty liver disease","volume":"21","author":"Newton","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2026.01.008_bib38","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1210\/clinem\/dgaa753","article-title":"Adolescent nonalcoholic fatty liver disease and type 2 diabetes in young adulthood","volume":"106","author":"Bardugo","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.cld.2026.01.008_bib39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jama.2018.20579","article-title":"Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: a randomized clinical trial","volume":"321","author":"Schwimmer","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.cld.2026.01.008_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12872","article-title":"The effects of mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"17","author":"Yurtdas","year":"2022","journal-title":"Pediatr Obes"},{"issue":"1","key":"10.1016\/j.cld.2026.01.008_bib41","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1186\/s12889-024-19378-w","article-title":"Efficacy of the mediterranean diet in treating metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents: a systematic review and meta-analysis","volume":"24","author":"Jamil","year":"2024","journal-title":"BMC Public Health"},{"issue":"6","key":"10.1016\/j.cld.2026.01.008_bib42","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3945\/ajcn.2010.30185","article-title":"Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption","volume":"92","author":"Davis","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.cld.2026.01.008_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0314542","article-title":"Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease","volume":"19","author":"Smith","year":"2024","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.cld.2026.01.008_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168216","article-title":"Docosahexanoic acid plus vitamin D treatment improves features of NAFLD in children with serum vitamin D deficiency: results from a single centre trial","volume":"11","author":"Della Corte","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cld.2026.01.008_bib45","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1515\/jpem-2020-0642","article-title":"Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial","volume":"34","author":"Saneian","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"16","key":"10.1016\/j.cld.2026.01.008_bib46","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cld.2026.01.008_bib47","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00431-021-04243-4","article-title":"Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial","volume":"181","author":"El Amrousy","year":"2022","journal-title":"Eur J Pediatr"},{"issue":"11","key":"10.1016\/j.cld.2026.01.008_bib48","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/apt.12758","article-title":"Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis","volume":"39","author":"Alisi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cld.2026.01.008_bib49","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/MPG.0b013e31821f9b85","article-title":"Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease","volume":"52","author":"Vajro","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.cld.2026.01.008_bib50","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1053\/j.gastro.2016.08.027","article-title":"In children with nonalcoholic fatty liver disease, cysteamine bitartrate delayed release improves liver enzymes but does not reduce disease activity scores","volume":"151","author":"Schwimmer","year":"2016","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2026.01.008_bib51","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/jpn3.12312","article-title":"Effect of N-acetyl cysteine in children with metabolic dysfunction-associated steatotic liver disease-A pilot study","volume":"79","author":"Babu Balagopal","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.cld.2026.01.008_bib52","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MPG.0000000000003796","article-title":"An open label, randomized, multicenter study of elafibranor in children with nonalcoholic steatohepatitis","volume":"77","author":"Goyal","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.cld.2026.01.008_bib53","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hep.32403","article-title":"Randomized placebo-controlled trial of losartan for pediatric NAFLD","volume":"76","author":"Vos","year":"2022","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cld.2026.01.008_bib54","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","article-title":"Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat Med"},{"issue":"10019","key":"10.1016\/j.cld.2026.01.008_bib55","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:59:07Z","timestamp":1778878747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326126000085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1089326126000085"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2026.01.008","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What\u2019s New in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2026.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}